최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Journal of controlled release : official journal of the Controlled Release Society, v.150 no.1, 2011년, pp.56 - 62
Oh, Y.J. (133-791, Republic of Korea) , Lee, J. (Department of Internal Medicine, Hanyang University College of Medicine, Seoul 133-791, Republic of Korea) , Seo, J.Y. , Rhim, T. , Kim, S.H. , Yoon, H.J. , Lee, K.Y.
Inhaling corticosteroids, such as budesonide (BD), is the most common treatment for asthma. However, frequent steroid administration is associated with many side effects. We hypothesized that porous microparticles containing BD could provide an effective treatment method for asthma, as t...
Immunol. Cell Biol. Kumar 79 141 2001 10.1046/j.1440-1711.2001.00981.x Murine model of chronic human asthma
J. Appl. Physiol. Edwards 84 379 1998 10.1152/jappl.1998.85.2.379 Recent advances in pulmonary drug delivery using large, porous inhaled particles
Eur. J. Pharm. Sci. Adi 35 12 2008 10.1016/j.ejps.2008.05.009 Micro-particle corrugation, adhesion and inhalation aerosol efficiency
Br. Med. J. Brown 1 585 1972 10.1136/bmj.1.5800.585 Beclomethasone dipropionate: a new steroid aerosol for the treatment of allergic asthma
J. Clin. Endocrinol. Metab. Samaras 90 4394 2005 10.1210/jc.2005-0036 Iatrogenic Cushing's syndrome with osteoporosis and secondary adrenal failure in human immunodeficiency virus-infected patients receiving inhaled corticosteroids and ritonavir-boosted protease inhibitors: six cases
Int. J. Pharm. Varshosaz 365 69 2009 10.1016/j.ijpharm.2008.08.034 Synthesis and evaluation of dextran-budesonide conjugates as colon specific prodrugs for treatment of ulcerative colitis
J. Control. Release Nakamura 61 329 1999 10.1016/S0168-3659(99)00150-9 Uptake and release of budesonide from mucoadhesive, pH-sensitive copolymers and their application to nasal delivery
J. Pharm. Sci. El-gendy 98 2731 2009 10.1002/jps.21630 Budesondie nanoparticle agglomerates as dry powder aerosols with rapid dissolution
Int. J. Pharm. Krishnamachari 338 238 2007 10.1016/j.ijpharm.2007.02.015 Development of pH-and time-dependent oral microparticles to optimize budesonide delivery to ileum and colon
Respir. Med. Dahl 100 1307 2006 10.1016/j.rmed.2005.11.020 Systemic side effects of inhaled corticosteroids in patients with asthma
Trends Biotechnol. Sung 25 563 2007 10.1016/j.tibtech.2007.09.005 Nanoparticles for drug delivery to the lungs
Proc. Natl Acad. Sci. USA Tsapis 99 12001 2002 10.1073/pnas.182233999 Trojan particles: large porous carriers of nanoparticles for drug delivery
Pharm. Res. Fiegel 20 788 2003 10.1023/A:1023441804464 Large porous particle impingement on lung epithelial cell monolayers-toward improved particle characterization in the lung
J. Control. Release Chono 137 104 2009 10.1016/j.jconrel.2009.03.019 Aerosolized liposomes with dipalmitoyl phosphatidylcholine enhance pulmonary insulin delivery
J. Control. Release Cook 104 79 2005 10.1016/j.jconrel.2005.01.003 Novel sustained release microspheres for pulmonary drug delivery
Science Edwards 276 1868 1997 10.1126/science.276.5320.1868 Large porous particles for pulmonary drug delivery
J. Pharm. Sci. Xu 98 2377 2009 10.1002/jps.21612 Preparation and characterization of negatively charged poly(lactic-co-glycolic acid) microsphereas
Biomaterials Kumar 25 1771 2004 10.1016/j.biomaterials.2003.08.069 Preparation and characterization of cationic PLGA nanospheres as DNA carriers
Eur. J. Pharm. Sci. Lee 29 435 2006 10.1016/j.ejps.2006.08.005 In vitro study of lysozyme in poly(lactide-co-glycolide) microspheres with sucrose acetate isobutyrate
Colloids Surf. B Xie 67 199 2008 10.1016/j.colsurfb.2008.08.018 Effect of PLGA as a polymeric emulsifier on preparation of hydrophilic protein-loaded solid lipid nanoparticles
J. Control. Release Rawat 128 224 2008 10.1016/j.jconrel.2008.03.013 Inhalable large porous microparticles of low molecular weight heparin: in vitro and in vivo evaluation
J. Control. Release Ungaro 135 25 2009 10.1016/j.jconrel.2008.12.011 Insulin-loaded PLGA/cyclodextrin large porous particles with improved aerosolization properties: in vitro deposition and hypoglycaemic activity after delivery to rat lungs
Biomaterials Yang 30 1947 2009 10.1016/j.biomaterials.2008.12.044 Development of highly porous large PLGA microparticles for pulmonary drug delivery
Biomaterials Jain 21 2475 2000 10.1016/S0142-9612(00)00115-0 The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices
Eur. J. Pharm. Sci. Ungaro 28 423 2006 10.1016/j.ejps.2006.05.005 Cyclodextrins in the production of large porous particles: development of dry powders for the sustained release of insulin to the lungs
J. Pharm. Pharmacol. Bandi 57 851 2005 10.1211/0022357056334 Intratracheal budesonide-poly(lactide-co-glycolide) microparticles reduce oxidative stress, VEGF expression, and vascular leakage in a benzo(a)pyrene-fed mouse model
J. Appl. Physiol. Wager 96 2019 2004 10.1152/japplphysiol.00924.2003 The allergic mouse model of asthma: normal smooth muscle in an abnormal lung?
J. Control. Release Arnold 121 100 2007 10.1016/j.jconrel.2007.05.039 Nanocipro encapsulation in monodisperse large porous PLGA microparticles
Polymer Mikos 35 1068 1994 10.1016/0032-3861(94)90953-9 Preparation and characterization of poly(l-lactic acid) foams
J. Control. Release Kim 112 167 2006 10.1016/j.jconrel.2006.02.004 Biodegradable polymic microspheres with “open/closed” pores for sustained release of human growth hormone
Int. J. Pharm. Kwon 333 5 2007 10.1016/j.ijpharm.2007.01.016 Long acting porous microparticle for pulmonary protein delivery
Biomaterials Kim 27 152 2006 10.1016/j.biomaterials.2005.05.081 Gas foamed open porous biodegradable polymeric microspheres
J. Toxicol. Environ. Health Schlesinger 15 197 1985 10.1080/15287398509530647 Comparative deposition of inhaled aerosols in experimental animals and humans: a review
Pharm. Res. Koushik 21 524 2004 10.1023/B:PHAM.0000019308.25479.a4 Preparation of large porous deslorelin-PLGA microparticles with reduced residual solvent and cellular uptake using a supercritical carbon dioxide process
Pharm. Res. Koushik 21 1119 2004 10.1023/B:PHAM.0000032997.96823.88 Pulmonary delivery of deslorelin: large-porous PLGA particles and HPβCD complexes
Am. J. Respir. Crit. Care Med. Hamelmann 156 766 1997 10.1164/ajrccm.156.3.9606031 Noninvasive measurement of airway responsiveness in allergic mice using barometric plethysmography
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.